Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Kaffenberger

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
HLA-B Alleles with Shared Peptide Binding Specificities Define Global Risk of Cotrimoxazole-induced SCARYueran Li, Andrew Gibson, Hajirah N Saeed, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 10, 2025
HLA-B Alleles With Shared Peptide Binding Specificities Define Global Risk of Co-trimoxazole-Induced Severe Cutaneous Adverse Drug ReactionsYueran Li, Andrew Gibson, Hajirah N Saeed, et al.
Journal for Immunotherapy of Cancer|April 10, 2024
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapySteven T Chen, Yevgeniy R Semenov, Allireza Alloo, et al.
Frontiers in Medicine|October 30, 2023
Updates in SJS/TEN: collaboration, innovation, and communityMadeline E Marks, Ramya Krishna Botta, Riichiro Abe, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
HLA-B Alleles with Shared Peptide Binding Specificities Define Global Risk of Cotrimoxazole-induced SCARYueran Li, Andrew Gibson, Hajirah N Saeed, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 10, 2025
HLA-B Alleles With Shared Peptide Binding Specificities Define Global Risk of Co-trimoxazole-Induced Severe Cutaneous Adverse Drug ReactionsYueran Li, Andrew Gibson, Hajirah N Saeed, et al.
Journal for Immunotherapy of Cancer|April 10, 2024
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapySteven T Chen, Yevgeniy R Semenov, Allireza Alloo, et al.
Frontiers in Medicine|October 30, 2023
Updates in SJS/TEN: collaboration, innovation, and communityMadeline E Marks, Ramya Krishna Botta, Riichiro Abe, et al.
Pageof 4